美国Astex  
Dacogen药物用于治疗急性髓细胞性白血病　
 
Astex Pharmaceuticals™ is a leader in innovative drug discovery, development and commercialization, committed to the fight against cancer and other life-threatening diseases.
Fiscal strength with significant cash, ongoing revenues and potential milestone payments
Productive partnerships with top-tier pharmaceutical companies
Rich product portfolio with multiple drugs in clinical development
Visionary leadership backed by a world-class management team
Oncology Focused We are a leader in innovative small-molecule therapeutics with particular expertise in fragment-based drug discovery, the most important advance in discovery chemistry in the last 20 years. Our primary areas of focus are oncology and hematology. Financially Strong We are a publicly traded pharmaceutical company with strong cash reserves and royalty revenues from the sales of our product DACOGEN®. In addition, our partnerships could deliver nearly $2 billion in product milestones plus royalties.